Article Details
Retrieved on: 2024-02-18 18:01:03
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Eli Lilly & Co's potential to become the first U.S. biopharma company to reach a $1 trillion market cap, following strong performance driven by successful drugs like Mounjaro and Zepbound.
Article found on: www.businesstimes.com.sg
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here